Nuwellis (NASDAQ: NUWE) stock soared over 50% in intraday trading following the release of its Q1 earnings report, which beat expectations.
Nuwellis (NUWE) recently released its first-quarter financial results, showcasing a mixed performance with better-than-expected earnings per share (EPS) but revenues falling below estimates.
The company reported earnings per share of -60 cents, beating the consensus estimate of -93 cents. However, revenues for the quarter totaled $1.9 million, representing a 2% year-over-year increase but falling short of the analyst estimate of $2.12 million.
The primary drivers for the revenue growth included an 11% rise in consumable utilization, particularly in the pediatric sector, which saw a significant 40% increase in revenue. Despite this overall growth, Nuwellis experienced a decline in heart failure revenue by 38% due to reduced utilization and consult sales.
Despite the mixed performance in the first quarter, Nuwellis remains optimistic about its growth prospects. The company forecasts a rise in capital sales in the coming year, supported by a robust pipeline of new accounts. The company ended the quarter with $1.4 million in cash and cash equivalents and recently bolstered its financial position by raising an additional $2.7 million through an underwritten public offering on April 30th.
Nuwellis (NASDAQ: NUWE) Stock Price Action
NUWE stock surged 54.03% to close at $0.2634 on Tuesday. Its value has been increased by 70.60% this week. Trading activity has witnessed 134,348,832 (134.34 million) shares changing hands, well above the average daily volume of 2.79 million.
Zabih Ullah is a seasoned finance writer with more than ten years of experience. He is highly skilled at analyzing market trends, decoding economic data, and providing insightful commentary on various financial topics. Driven by his curiosity, Zabih stays updated with the latest developments in the finance industry, ensuring that his readers receive timely and relevant news and analysis. Read Full Bio
